Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
Yi Tan, Zhiguo Zhang, Chao Zheng, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 9, pp. 585-607
Open Access | Times Cited: 565

Showing 26-50 of 565 citing articles:

Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress
Xuemei Gu, Yujuan Shi, Xiaojun Chen, et al.
Phytomedicine (2020) Vol. 78, pp. 153319-153319
Closed Access | Times Cited: 73
MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics
Daniel Jakubik, Alex Fitas, Ceren Eyileten, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 72
FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress
Lin Chen, Yongzhen Guo, Yunlong Xia, et al.
Journal of Molecular and Cellular Cardiology (2021) Vol. 160, pp. 27-41
Closed Access | Times Cited: 69
Oxidative stress in metabolic diseases: current scenario and therapeutic relevance
Satish K. Raut, Madhu Khullar
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 1, pp. 185-196
Closed Access | Times Cited: 62
Diabetic heart disease: A clinical update
Jake Rajbhandari, Cornelius James Fernandez, Mayuri Agarwal, et al.
World Journal of Diabetes (2021) Vol. 12, Iss. 4, pp. 383-406
Open Access | Times Cited: 59
Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
Cuncun Hua, Xinming Liu, Lirong Liang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 57
Cellular senescence and cardiovascular diseases: moving to the “heart” of the problem
Konstantinos Evangelou, Panagiotis Vasileiou, Angelos Papaspyropoulos, et al.
Physiological Reviews (2022) Vol. 103, Iss. 1, pp. 609-647
Open Access | Times Cited: 57
Nicotinamide riboside promotes Mfn2-mediated mitochondrial fusion in diabetic hearts through the SIRT1-PGC1α-PPARα pathway
Lang Hu, Yanjie Guo, Liqiang Song, et al.
Free Radical Biology and Medicine (2022) Vol. 183, pp. 75-88
Open Access | Times Cited: 46
CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis
Lin Chen, Zhiqiang Yin, Xing Qin, et al.
Pharmacological Research (2022) Vol. 176, pp. 106086-106086
Closed Access | Times Cited: 45
Empagliflozin Ameliorates Diabetic Cardiomyopathy via Attenuating Oxidative Stress and Improving Mitochondrial Function
J. Wang, Xinyuan Huang, H.o-Ling Liu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 45
Protective role of hydrogen sulfide against diabetic cardiomyopathy via alleviating necroptosis
Weiwei Gong, Shuping Zhang, Yun Chen, et al.
Free Radical Biology and Medicine (2022) Vol. 181, pp. 29-42
Closed Access | Times Cited: 44
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
Wu Luo, Ke Lin, Junyi Hua, et al.
Advanced Science (2022) Vol. 9, Iss. 31
Open Access | Times Cited: 41
New Insights into the Role of Ferroptosis in Cardiovascular Diseases
Anna Maria Fratta Pasini, Chiara Stranieri, Fabiana Busti, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 867-867
Open Access | Times Cited: 33
Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective
Mehrdad Hashemi, Mohammad Arad Zandieh, Setayesh Ziaolhagh, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 5, pp. 166714-166714
Open Access | Times Cited: 32
Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance
Elena Succurro, Francesco Cicone, Annalisa Papa, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies
Nilanjan Ghosh, Leena Chacko, Hiranmoy Bhattacharya, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1126-1126
Open Access | Times Cited: 29
Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
Yanan Cheng, Yan Wang, Ruili Yin, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 28
Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAs
Mirjana Mačvanin, Zoran Gluvić, Jelena Radovanović, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 27
Curcumin Improves Diabetic Cardiomyopathy by Inhibiting Pyroptosis through AKT/Nrf2/ARE Pathway
Wei Zhang, Pinfang Kang, Jing Zhou, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-20
Open Access | Times Cited: 25
Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation
Keshav Gopal, Qutuba G. Karwi, Seyed Amirhossein Tabatabaei Dakhili, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Pyroptosis: Mechanisms and links with diabetic cardiomyopathy
Pan Liu, Zhengdong Zhang, Huizhen Chen, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102182-102182
Closed Access | Times Cited: 15
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial
James L. Januzzi, Stefano Del Prato, Julio Rosenstock, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Cardiomyocyte LGR6 alleviates ferroptosis in diabetic cardiomyopathy via regulating mitochondrial biogenesis
Mengmeng Zhao, Zican Shen, Zihui Zheng, et al.
Metabolism (2024) Vol. 159, pp. 155979-155979
Closed Access | Times Cited: 13
Histone acetyltransferase Kat2a regulates ferroptosis via enhancing Tfrc and Hmox1 expression in diabetic cardiomyopathy
Juan Zhen, Xia Sheng, Tianlong Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 11
Interleukin-1β polarization in M1 macrophage mediates myocardial fibrosis in diabetes
Wenli Guo, Chen Yang, Jiawei Zou, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111858-111858
Closed Access | Times Cited: 10

Scroll to top